Editorial: Toward Personalized Treatment for Systemic Juvenile Idiopathic Arthritis

Affiliations

¹ University Medical Center Utrecht, Utrecht, The Netherlands.
² Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

Editorial

Sebastiaan J Vastert et al. Arthritis Rheumatol. 2018 Aug.

. 2018 Aug;70(8):1172-1174.

doi: 10.1002/art.40501. Epub 2018 Jun 29.

¹ University Medical Center Utrecht, Utrecht, The Netherlands.
² Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

No abstract available

Comment on

IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis.
Arthur VL, Shuldiner E, Remmers EF, Hinks A, Grom AA, Foell D, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Oliveira S, Yeung RSM, Rosenberg AM, Wedderburn LR, Anton J, Haas JP, Rösen-Wolff A, Minden K, Szymanski AM; INCHARGE Consortium; Thomson W, Kastner DL, Woo P, Ombrello MJ. Arthur VL, et al. Arthritis Rheumatol. 2018 Aug;70(8):1319-1330. doi: 10.1002/art.40498. Epub 2018 Jun 28. Arthritis Rheumatol. 2018. PMID: 29609200 Free PMC article.

1. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med. 2005;201:1479–1486. - PMC - PubMed
1. Nigrovic PA, Mannion M, Zeft AS, Rabinovich EC, Rossum MAJVan, Cortis E, et al. Anakinra as first-line disease modifying therapy in systemic juvenile idiopathic arthritis report of 46 patients from an international multicenter series. Arthritis Rheum. 2010;62:209. Available at: http://www.embase.com/search/results?subaction=viewrecord&from=export&id.... - PubMed
1. Vastert SJ, Jager W, de Noordman BJ, Holzinger D, Kuis W, Prakken BJ, et al. Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study. Arthritis Rheumatol. 2014;66:1034–1043. Available at: http://doi.wiley.com/10.1002/art.38296. - DOI - PubMed
1. Nigrovic PA. Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis? Arthritis Rheumatol (Hoboken, NJ) 2014;66:1405–1413. - PubMed
1. Benedetti FDe, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367:2385–95. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23252525. - PubMed